ADA Scientific Sessions 2026 Abstract
Efficacy and Hypoglycemia Outcomes with Once-Weekly IcoSema vs. Comparators in T2D by Baseline BMI: COMBINE 1–3
Trial in peopleInterventions
Papers by Cathrine Scavenius
2 results
- ADA Scientific Sessions 2026 Abstract
Efficacy and Hypoglycemia Outcomes with Once-Weekly IcoSema vs. Comparators in T2D by Baseline A1C: COMBINE 1–3
Trial in peopleInterventions